INNOCORP (INNOCORP) Fair Value & Analysis
IN · Market cap ₹29.0M
Fair value as of: Jul 5, 2026
From 6 valuation models · updated today
Share price −9.0% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹3.65 – ₹5.82 · the ₹3.65 price screens above the ₹2.86 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
INNOCORP (INNOCORP) currently trades at ₹3.65, while our model-based Fair Value estimate is ₹2.86 — implying the stock looks roughly 21.6% overvalued today. We read business quality at 46/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, INNOCORP generated revenue of ₹2.1M at a net margin of -19.7%. It earns a return on equity of -1.8%. Net debt stands at ₹38.2M. Fundamentals as of Jul 5, 2026
The share trades about 40% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
INNOCORP reported revenue of ₹2.1M in FY2025 versus ₹5.2M in FY2021, a compound −20.0%/yr. Reported net income was −₹419K in FY2025.
Is INNOCORP fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is INNOCORP (INNOCORP) undervalued?
What is the fair value of INNOCORP?
What is the quality score of INNOCORP?
What is the revenue of INNOCORP (INNOCORP)?
What is the net profit margin of INNOCORP?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.